PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Glycyrrhizic Acid→

Glycyrrhizic Acid PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
1405-86-3
Molecular formula
C42H62O16
Molecular weight
822.9 g/mol
Drug class
Triterpenoid saponinlicorice-derived anti-inflammatory and hepatoprotective constituent
Mechanism of action
Glycyrrhizic acid is metabolised to glycyrrhetinic acid and related metabolites. Proposed activities include modulation of HMGB1 and NF-kB signalling, anti-inflammatory and antioxidant effects, membrane stabilisation and modulation of cortisol metabolism. These actions depend on formulation and metabolism; the compound can also cause mineralocorticoid-like adverse effects through inhibition of 11β-hydroxysteroid dehydrogenase.
Indications / reported uses
  • Used as an active constituent in certain licorice-derived hepatoprotective and anti-inflammatory preparations in some jurisdictions; exact indications are formulation- and jurisdiction-specific. It is not a stand-alone universal treatment for liver disease.

Sources: https://pubmed.ncbi.nlm.nih.gov/41789596/ · https://pubmed.ncbi.nlm.nih.gov/42147312/ · https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diammonium-glycyrrhizinate · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Glycyrrhizic Acid PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Glycyrrhizic Acid Permitted Daily Exposure (PDE) report (the Glycyrrhizic Acid PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Glycyrrhizic Acid Occupational Exposure Limit (OEL) report (the Glycyrrhizic Acid OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.